Epidermal Barrier Dysfunction in Atopic Dermatitis
Michael J. Cork(University of Sheffield), Simon Ward(University of Sheffield), Simon G. Danby(University of Sheffield), Majella E. Lane(University of London), Alice MacGowan, Rachid Tazi‐Ahnini(University of Sheffield), Richard H. Guy(University of Bath), Yiannis Vasilopoulos(University of Sheffield), Manar Moustafa(University of Sheffield), Jonathan Hadgraft(University of London)
Cited by 756
Related Papers
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
Application of the threshold of toxicological concern (TTC) to the safety evaluation of cosmetic ingredients
|Food and Chemical Toxicology|2007|1.8k
Predicting Skin Permeability
|Pharmaceutical Research|1992|1.5k
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
|Nature Genetics|2012|1k
Iontophoretic drug delivery
|Advanced Drug Delivery Reviews|2003|845